Skip to main content

Table 8 Crude Relative Risk of Venous Thromboembolism in Cisplatin based regimens

From: Incidence of Venous Thromboembolism in cancer patients treated with Cisplatin based chemotherapy — a cohort study

  Incidence proportion Relative Risk (95% CI)
Cisplatin group 31/200 2.81* (1.4–4.2)
Non-Cisplatin group 11/200  
  1. *p < 0.05